Patient Prognosis
suPARnostic® - as single measurement - provides a higher value in predicting mortality risk than the SOFA and SAPS II scores (6 and 12 parameters).
suPARnostic®: Certainty in Patient Prognosis and Decision Making
Acute Triaging
suPARnostic® helps identify potentially critical cases early and decide who to treat first - a high suPARnostic® level (5 and above) is indicative of a critical patient condition and increased risk of mortality.
Effective Treatment
suPARnostic® makes it easy to monitor treatment response with one simple blood test - a decreasing suPARnostic® level indicates patient improvement and effective intervention.
Thus suPAR can be used to triage patient samples, measure treatment response and further document reached endpoints. suPAR's high stability and uniform kinetics make it a reliable clinical biomarker – it beats other markers used for similar purposes.
